Your browser doesn't support javascript.
loading
Lifetime cardiovascular management of patients with previous Kawasaki disease.
Brogan, Paul; Burns, Jane C; Cornish, Jacqueline; Diwakar, Vinod; Eleftheriou, Despina; Gordon, John B; Gray, Huon Hamilton; Johnson, Thomas William; Levin, Michael; Malik, Iqbal; MacCarthy, Philip; McCormack, Rachael; Miller, Owen; Tulloh, Robert M R.
Afiliação
  • Brogan P; Infection, Inflammation, and Rheumatology, UCL Institute of Child Health, London, UK.
  • Burns JC; Pediatrics, University of California, San Diego, California, USA.
  • Cornish J; Pediatrics, Rady Children's Hospital San Diego, San Diego, California, USA.
  • Diwakar V; National Clinical Director Children, Young People and Transition to Adulthood, Medical Directorate, NHS England, London, UK.
  • Eleftheriou D; NHS Improvement, NHS England, London, UK.
  • Gordon JB; Infection, Inflammation, and Rheumatology, UCL Institute of Child Health, London, UK.
  • Gray HH; Cardiology, Sharp Memorial Hospital and San Diego Cardiac Center, San Diego, California, USA.
  • Johnson TW; National Clinical Director for Heart Disease, NHS England, London, UK.
  • Levin M; Cardiology, Bristol Heart Institute, Bristol, UK.
  • Malik I; Paediatrics, Imperial College London, London, UK.
  • MacCarthy P; Imperial College London, International Centre for Circulatory Health, London, UK.
  • McCormack R; Cardiology, Kings College Hospital, London, UK.
  • Miller O; Societi, The UK Foundation for Kawasaki Disease, Newark, UK.
  • Tulloh RMR; Department of Congenital Heart Disease, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Heart ; 106(6): 411-420, 2020 03.
Article em En | MEDLINE | ID: mdl-31843876
ABSTRACT
Kawasaki disease (KD) is an inflammatory disorder of young children, associated with vasculitis of the coronary arteries with subsequent aneurysm formation in up to one-third of untreated patients. Those who develop aneurysms are at life-long risk of coronary thrombosis or the development of stenotic lesions, which may lead to myocardial ischaemia, infarction or death. The incidence of KD is increasing worldwide, and in more economically developed countries, KD is now the most common cause of acquired heart disease in children. However, many clinicians in the UK are unaware of the disorder and its long-term cardiac complications, potentially leading to late diagnosis, delayed treatment and poorer outcomes. Increasing numbers of patients who suffered KD in childhood are transitioning to the care of adult services where there is significantly less awareness and experience of the condition than in paediatric services. The aim of this document is to provide guidance on the long-term management of patients who have vascular complications of KD and guidance on the emergency management of acute coronary complications. Guidance on the management of acute KD is published elsewhere.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Síndrome de Linfonodos Mucocutâneos Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Síndrome de Linfonodos Mucocutâneos Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article